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Abstract
Plants produce an immense variety of specialized metabolites, many of which are of high value as their bioactive properties
make them useful as for instance pharmaceuticals. The compounds are often produced at low levels in the plant, and due to
their complex structures, chemical synthesis may not be feasible. Here, we take advantage of the reducing equivalents
generated in photosynthesis in developing an approach for producing plant bioactive natural compounds in a
photosynthetic microorganism by functionally coupling a biosynthetic enzyme to photosystem I. This enables driving of the
enzymatic reactions with electrons extracted from the photosynthetic electron transport chain. As a proof of concept, we
have genetically fused the soluble catalytic domain of the cytochrome P450 CYP79A1, originating from the endoplasmic
reticulum membranes of Sorghum bicolor, to a photosystem I subunit in the cyanobacterium Synechococcus sp. PCC 7002,
thereby targeting it to the thylakoids. The engineered enzyme showed light-driven activity both in vivo and in vitro,
demonstrating the possibility to achieve light-driven biosynthesis of high-value plant specialized metabolites in
cyanobacteria.
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Introduction
Sunlight is an inexhaustible and abundant source of clean
energy that, through photosynthesis, can be harvested by plants,
algae and cyanobacteria. The amount of light energy captured in
photosynthesis is often larger than what can be used by the
photosynthetic metabolic reactions. This suggests a potential for
utilizing photosynthetic organisms in biotechnology, as the excess
electrons generated in photosynthesis could be applied in
sustainable production of biofuels and high-value chemical
compounds [1]. Using a synthetic biology approach, a photosyn-
thetic organism can be engineered to take advantage of this excess
reducing power. By transferring enzymes that catalyse reactions of
interest into the vicinity of the thylakoids, it is possible to tap
directly into the photosynthetic electron transport chain and re-
direct some of the electrons towards production of valuable
bioactive compounds [1,2].
Plants synthesize a vast array of bioactive molecules, many of
which have properties that make them useful as pharmaceuticals,
biopesticides, flavours, fragrances or colours [3,4]. Examples
include paclitaxel from Taxus brevifolia and vincristine and
vinblastine from Catharanthus roseus, which are all used in cancer
treatment, and the anti-malarial agent artemisinin from Artemisia
annua [5–7]. Often these compounds are of high market value,
but are synthesized at low levels in the plants and are difficult to
produce chemically due to their highly complex structures [4,8,9].
A group of enzymes often involved in the biosynthesis pathways of
these molecules, catalysing key steps with high regio- and
stereospecificity, is the cytochrome P450s (P450s). P450s are
typically monooxygenases, catalysing the cleavage of O2 and
incorporation of an oxygen atom in a wide variety of different
substrates [10–12]. In plants, P450s are mainly found in the
membranes of the endoplasmic reticulum (ER) and receive the
electrons needed for their reactions from NADPH via a NADPH-
cytochrome P450 oxidoreductase (POR) [13].
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In this report it is our aim to construct a microbial in vivo
production system for plant specialized metabolites, in which the
POR is omitted and instead the electrons for the P450s are
supplied from the photosynthetic electron transport chain.
In oxygenic photosynthesis, electrons are extracted from water
by photosystem II (PSII) and delivered to photosystem I (PSI) via
an electron transport chain [14,15]. PSI utilizes energy from light
to excite electrons and transfers them to ferredoxin (Fd), a small
soluble redox protein, which in turn reduces proteins of different
electron-requiring processes in the stroma of the chloroplast or
cytosol of cyanobacteria, primarily the ferredoxin-NADP+ reduc-
tase (FNR), which catalyses the reduction of NADP+ to NADPH.
The structure and function of PSI is highly conserved between
organisms, the core of the complex even being remarkably
conserved between cyanobacteria and higher plants despite a
billion years of separate evolution [16,17]. In addition, the high
stability and quantum yield of PSI make it useful in bio-engineered
production systems [18].
As a model system to investigate the effect of functionally
coupling PSI and a plant P450, we have chosen the P450
CYP79A1 from the biosynthesis pathway of the cyanogenic
glucoside dhurrin (b-D-glucopyranosyloxy-(S)-p-hydroxymandelo-
nitrile) in the crop grass Sorghum bicolor. The dhurrin biosynthesis
pathway consists of two membrane-anchored P450s, CYP79A1
and CYP71E1, and a soluble UDP-glucosyltransferase,
UGT85B1. CYP79A1 is the first enzyme in the pathway and
converts the substrate tyrosine into p-hydroxyphenylacetaldoxime
(oxime) [19,20].
We have previously shown that Fd is capable of mediating
electron transfer from PSI directly to the CYP79A1 in vitro,
thereby enabling oxime production with high efficiency [13]. The
versatility of the approach of light-driven P450 reactions was
demonstrated by showing that the system was not only functional
with the plant CYP79A1, but also with a bacterial P450, the
CYP124 from Mycobacterium tuberculosis [21]. More recently, we
transiently expressed the entire dhurrin biosynthesis pathway in
the tobacco Nicotiana benthamiana, where it was targeted to the
chloroplast by transit peptides [2]. The two P450s were inserted in
the thylakoid membrane and demonstrated to be driven by the
photosynthetic reducing power.
In the present study we aimed at developing an in vivo-
functional light-driven microbial production system by stably
expressing a fusion protein of the catalytic domain of CYP79A1
and a PSI subunit, functioning as a thylakoid-targeting membrane
anchor, in a cyanobacterium. Using a photosynthetic microor-
ganism as host organism provides the opportunity for future scale-
up to industrial production levels.
For the cyanobacterium to be viable, only a part of the electrons
from PSI should be delivered to the CYP79A1 via freely diffusible
Fd. The peripheral, membrane embedded PSI subunit PsaM was
chosen as anchor point for the CYP79A1 (Figure 1), as this should
allow access of Fd to its docking site at PSI, even if the
recombinant PsaM-CYP79A1 subunit remained bound to PSI in
a PSI-CYP79A1 supercomplex, and ensure partition of electrons
to both the CYP79A1 as well as to other proteins relying on
reduction by Fd [22]. Proximity of the CYP79A1 to PSI should be
beneficial in the competition for reduced Fd, as close confinement
has been shown to be an advantage for the efficient electron
transfer between interacting proteins in crowded environments like
the thylakoids [23].
The PsaM-CYP79A1 fusion protein was shown to hydroxylate
tyrosine to the corresponding oxime both in vivo and in vitro.
Despite the fact that only a fraction of the fusion protein was found
to be associated with PSI upon purification, the recombinant P450
was active without its native membrane anchor and its activity was
indeed sustained by the photosynthetic electrons. Interestingly, the
produced oxime was excreted into the growth medium, facilitating
simple product isolation.
Materials and Methods
Construction of the psaM-CYP79A1 fusion
A psaM-CYP79A1 fusion construct was designed as a DNA
sequence encoding amino acid 1-25 of Synechococcus sp. PCC
7002 PsaM, corresponding to the membrane spanning part of the
protein, followed by a sequence encoding amino acid 36-558 of
the S. bicolor CYP79A1, corresponding to the part of the
CYP79A1 protruding from the membrane in the native protein,
codon optimized for expression in cyanobacteria. The construct
was commercially synthesized and inserted in the multi cloning site
of the pUC57 cloning vector by Genscript (http://www.genscript.
com/).
Genomic DNA (gDNA) was prepared from Synechococcus sp.
PCC 7002 as described by Bickley and Owen (1995) [24]. The
831 bp flanking region upstream and 791 bp flanking region
downstream of the psaM gene were amplified from the
Synechococcus sp. PCC 7002 gDNA using primer pair b and c,
respectively, and the npt cassette, conferring kanamycin resistance,
was amplified from the pJHJ08 vector ([25], gift from associate
professor Yumiko Sakuragi) using primer pair a by PCR (primers
are listed in Table 1). The fragments were cloned into the pUC57
construct in three consecutive cloning steps at EcoRI, BamHI and
BspEI sites as illustrated in Figure S1 to yield the psaM-CYP79A1
fusion construct.
Transformation of cyanobacteria
Transformation of Synechococcus sp. PCC 7002 with the fusion
construct to obtain the PsaM-CYP79A1 strain was performed as
described by Frigaard et al. (2004) [26]. The psaM gene was
replaced with the psaM-CYP79A1 gene through homologous
recombination. Transformants were selected for kanamycin
resistance and segregated for 4 generations before they were
screened for the presence of the fusion gene by colony PCR using
primer pairs d, g and h (Table 1).
Cyanobacterial strains and culture conditions
Two Synechococcus sp. PCC 7002 strains were used in this
study, wild type (WT) and the recombinant PsaM-CYP79A1
strain. Cyanobacterial cells were grown photoautotrophically in
medium A+ (medium A [27] containing 1 mg/mL NaNO3) at
38uC under continuous illumination at 80 mmol?m22?s21 with
aeration by 3% (v/v) CO2 in air or on A
+ agar plates containing
15 g/L Bacto agar. PsaM-CYP79A1 engineered cells were grown
in the presence of 200 mg/mL kanamycin. Cell growth was
monitored by measuring the absorbance at 730 nm (optical
density, OD730). The chlorophyll (Chl) content was measured after
extraction with 80% acetone as described by Lichtenthaler [28].
Cultures for experiments and isolation of thylakoids were started at
OD730 = 0.05. The cells were harvested when they were in the
late exponential phase as assessed by measuring the OD730.
RNA isolation and RT-PCR
RNA was isolated from 20 mL Synechococcus sp. PCC 7002
cultures grown to the late exponential phase. The cells were
harvested by centrifugation at 10,0006g for 3 min and the pellets
were resuspended in 100 mL double-distilled water. 100 mL glass
beads and 800 mL TRIzol reagent (Invitrogen) were added and the
samples were subjected to 6 rounds of freezing in liquid nitrogen,
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thawing and 1 min vigorous vortexing. After 5 min incubation at
room temperature (RT), 200 mL chloroform was added and the
samples were vortexed for 15 s, and incubated at RT for 3 min.
The phases were separated by centrifugation at 12,0006g for
10 min at 4uC and the upper phases transferred to new tubes.
500 mL isopropanol was added and the samples were incubated
for 10 min at RT, and centrifuged at 12,0006g for 10 min at 4uC.
The pellets were washed in 1 mL 70% ethanol by vortexing and
centrifugation at 7,5006g for 5 min at 4uC. The supernatants
were discarded and the pellets dried for 15 min before they were
dissolved in 100 mL RNase-free water. The RNA was purified
using the RNeasy Plant Mini Kit (Qiagen) and the concentrations
were measured to be 128 ng/mL for the WT and 202 ng/mL for
Figure 1. Localization of PsaM in PSI and schematic drawing of the thylakoid in the engineered strain. A) and B) The crystal structure of
a monomer of photosystem I from the cyanobacterium Thermosynechococcus elongatus seen from the cytoplasmic side of the thylakoid membrane
(A) and from the trimer-facing side of the monomer (B). RCSB Protein Data Bank ID: 1JB0. The PsaM subunit is shown in green in both panels and
additionally indicated by an arrow in panel A. C) Schematic representation of the PsaM-CYP79A1 fusion protein in the thylakoid membrane.
doi:10.1371/journal.pone.0102184.g001
Table 1. Sequences of oligonucleotide primers used in this study.
Primer name Sequence Restriction site
aFwd 59-GCGTCCGGACCGGAATTGCCAGCTGGG-39 BspEI
aRev 59-GCGGGATCCTCAGAAGAACTCGTCAAGAA-39 BamHI
bFwd 59-GCGGAATTCGTCACAAAACCTGCATCTTC-39 EcoRI
bRev 59-GCGGAATTCAATTTTAAAAACTCCGAATATAAAC-39 EcoRI
cFwd 59-GCGGGATCCTAAATCTGCCACAGAAGCAG-39 BamHI
cRev 59-GCGGGATCCTTTGTGTATCACACGCCTGA-39 BamHI
dFwd 59-GGAAACAGGCAAGGTCTGTA-39 -
dRev, gRev, hRev 59-GATTTGGGTCAGTTTGCGAC-39 -
eFwd, fFwd 59-ATGGGAATTTCTGATACCCAAG-39 -
eRev 59-GAGAGCCGGAAAGCCAAA-39 -
fRev 59-CGCAGGTGGTGGAACTAC-39 -
gFwd 59-GTTATCCGGCGTCTCATGTT-39 -
hFwd 59-GACTGGGCACAACAGACAAT-39 -
Restriction sites inserted into the PCR product through the primers are underlined.
doi:10.1371/journal.pone.0102184.t001
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the PsaM-CYP79A1 using a NanoDrop ND-1000 Spectropho-
tometer (Thermo Scientific).
The RNA was prepared for RT-PCR (reverse transcriptase
polymerase chain reaction) using the DNase I Amplification Grade
Kit (Sigma-Aldrich). cDNA was synthesized from the RNA using
the iScript cDNA Synthesis Kit (Bio-Rad) with the primer mixture
supplied with the kit (a mixture of oligo(dT) and random hexamer
primers). A control sample was made without reverse transcrip-
tase. The cDNA was used as template for PCR using primer pairs
e and f (Table 1).
In vivo PsaM-CYP79A1 activity
40 mL cultures of WT and PsaM-CYP79A1 were grown as
described above. Cells were separated from the growth medium by
centrifugation at 5,0006g for 10 min at 4uC. Metabolites were
extracted from the growth medium by vortexing with 1/3 volume
of ethyl acetate (EtOAc) three times. The cells were disrupted by
sonication (20 cycles of 30 s pulse amplitude 100, 90 s off) in a
Q700 sonicator (Qsonica) equipped with a cup horn. Samples
were centrifuged at 10,0006g for 10 min at 4uC and metabolites
were extracted from the supernatant into a double volume of
EtOAc by thorough vortexing. For both growth medium and cell
samples, the EtOAc phase was separated from the water phase by
centrifugation at 2,0006g for 5 min. The EtOAC was evaporated
in a Scanspeed 32 (Scanvac, Labogene). The samples were
resuspended in 80% methanol (MeOH), diluted to 20% MeOH in
water and subjected to liquid chromatography–mass spectrometry
(LC-MS) analysis (final volume 80 mL).
LC-MS analysis
Analytical LC-MS was carried out using an Agilent 1100 Series
LC (Agilent Technologies, Germany) coupled to a Bruker HCT-
Ultra ion trap mass spectrometer (Bruker Daltonics, Bremen,
Germany). A Zorbax SB-Aq column (Agilent; 3.5 mM,
2.16150 mm) was used at a flow rate of 0.2 mL min21. The
oven temperature was maintained at 35uC. The mobile phases
were: A, 2 mM ammonium acetate; B, methanol. The gradient
program was: 0 to 1 min, isocratic 25% B; 1 to 11 min, linear
gradient 25 to 60% B; 11 to 12 min, isocratic 98% B; 12 to
20 min, isocratic 25% B. The mass spectrometer was run in
positive APCI mode and the recorded mass range was m/z 80-
350.
Isolation of thylakoids and PSI from cyanobacteria
All steps were carried out in green safelight or dim light with
samples kept in the dark at 4uC or on ice. The cells were collected
by centrifugation at 7,5006g for 10 min at 4uC and washed once
in 20 mM Tricine-NaOH pH 7.5. The cells were then pelleted
again, resuspended in thylakoid buffer (20 mM Tricine-NaOH
pH 7.5, 0.4 M sucrose, 10 mM NaCl, 5 mM MgCl2, 1 mM
DTT, 5% (v/v) glycerol, 16Complete protease inhibitor cocktail
(Roche)) and disrupted in a single cycle at 20,000 psi in a TS Series
Benchtop cell disrupter (Constant Systems). Unbroken cells were
removed by centrifugation at 3,0006g for 10 min at 4uC and the
supernatant was subjected to ultracentrifugation at 184,0006g for
45 min at 4uC. The pellet, consisting of the thylakoids, was
carefully resuspended in thylakoid buffer using a small paintbrush.
If not to be used for isolation of PSI, the thylakoids were frozen in
liquid nitrogen.
For isolation of PSI, the thylakoids were solubilised in 1% (w/v)
n-dodecyl b-D-maltoside (b-DM) at a final concentration corre-
sponding to 1 mg Chl/mL (dilution in thylakoid buffer) by stirring
for 30 min on ice. Unsolubilised membranes were removed by
ultracentrifugation at 184,0006g for 30 min at 4uC. Supernatant
corresponding to 0.5 mg Chl was applied to 5-step 10–30%
sucrose gradients prepared as described by Chitnis and Chitnis
(1993) [29]. The sucrose gradients were ultracentrifuged at
270,0006g for 21 hours at 4uC and green bands were carefully
collected using a Pasteur pipette or 0.5 mL fractions were collected
using a peristaltic pump.
In vitro PsaM-CYP79A1 activity measurements
Thylakoids corresponding to 100 mg Chl were mixed with
2.6 mM (0.25 mCi) L-[U-14C] Tyrosine (Perkin Elmer) or 0–
1000 mM unlabelled tyrosine (Sigma-Aldrich), 0.15 mM spinach
Fd, 22.5 mM Synechococcus sp. PCC 7002 cytochrome c6 (cyt c6)
expressed in Escherichia coli, 3.6 mM sodium ascorbate, 0.11 mM
2,6-dichlorophenolindophenol (DCPIP), 1 mM dithiothreitol
(DTT) and 0.1% (w/v) b-DM in a 20 mM Tricine-NaOH buffer
pH 7.5 (total reaction volume 200 mL). Assay samples where
incubated at 25uC while illuminated with a Schott KL 1500 light
source at 200 mmol?m22?s21 for 30 min. The produced oxime was
extracted in EtOAc corresponding to twice the reaction volume by
vortexing. The EtOAc phase was separated from the assay mixture
by centrifugation at 2,0006g for 5 min, transferred to a new tube
and concentrated in a Scanspeed 32 vacuum concentrator. In
experiments using radiolabelled tyrosine as substrate, the sample
components were separated by thin layer chromatography (TLC)
using a toluene/EtOAc/MeOH (30:8:1 v/v) solvent mixture and a
Silica gel 60 F254 TLC plate (Merck). A dilution series of L-
[U-14C] Tyrosine was included on the plate to allow quantifica-
tion. The TLC plate was incubated with a storage phosphor screen
for 2 weeks and radiolabelled components were detected and
quantified using a Storm 840 PhosphorImager (Molecular
Dynamics). In the experiments where unlabelled tyrosine was
used as substrate, two samples were prepared for each data point
and the EtOAc pooled afterwards. Samples were prepared for and
subjected to LC-MS analysis as described above.
Immunoblot analysis
Thylakoid (proteins corresponding to 10 mg Chl) and PSI
(proteins corresponding to 50 mg Chl) or sucrose gradient fraction
samples (proteins from 80 mL of the 0.5 mL fractions collected
from the sucrose gradient, concentrated by acetone precipitation
by centrifugation at 20,0006g for 15 min at 4uC in a final
concentration of 80% acetone) were subjected to SDS-PAGE on
12% Criterion XT Bis-Tris gels (Bio-Rad) in XT MES Running
Buffer (Bio-Rad) at 200 V for 55 min. Proteins were transferred to
a Whatman Protran nitrocellulose membrane using a Criterion
blotter (Bio-Rad). The membrane was blocked in 5% (w/v)
skimmed milk in PBS buffer containing 0.05% (v/v) Tween-20
(PBS-T) for 1 h at RT and incubated overnight with a rabbit
CYP79A1 primary antibody (1:2000 dilution, gift from Tomas
Laursen) in 1% (w/v) skimmed milk in PBS-T at 4uC. For the
sucrose gradient fraction immunoblot, the membrane was cut in
three after the blocking step and the pieces were incubated with
the CYP79A1 primary antibody, a rabbit PsaC primary antibody
(1:1000 dilution, Agrisera) and a rabbit PsbA primary antibody
(1:10,000 dilution, Agrisera), respectively. The blot was washed
with PBS-T and incubated with a secondary horseradish
peroxidase (HRP)-conjugated swine anti-rabbit IgG antibody
(Dakopatts, 1:5000 dilution in PBS-T) for 1 h at RT. The
membrane was washed again in PBS-T and the secondary
antibody detected using SuperSignal West Dura Chemilumines-
cent Substrate (Pierce) with a BioSpectrum Imaging System
(UVP).
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BN-PAGE analysis
Blue-native polyacrylamide gel electrophoresis (BN-PAGE) was
performed by a procedure adapted from the laboratory of Prof.
Jo¨rg Nickelsen, Ludwig Maximilians University of Munich [30].
Briefly, thylakoids corresponding to 500 mg protein were pelleted
by centrifugation at 20,0006g for 20 min at 4uC and resuspended
in 50 mL ACA buffer (50 mM Bis-Tris, pH 7.0, 750 mM
aminocaproic acid, 0.5 mM EDTA). The thylakoids were
solubilized by adding 7.5 mL 10% (w/v) b-DM and incubating
on ice for 30 min. Samples were centrifuged at 20,0006g for
30 min at 4uC and supernatant was mixed with 8 mL loading
buffer (750 mM aminocaproic acid, 5% (w/v) Coomassie G-250).
25 mL sample was loaded on a NativePAGE Novex 4–16% Bis-
Tris Protein Gel (Life Technologies). Gel electrophoresis was
performed at 4uC by first running at 40 V constant for 7 h with
blue catode buffer (50 mM tricine, 15 mM Bis-Tris, pH 7.0, 0.2%
(w/v) Coomassie G-250) and clear anode buffer (50 mM Bis-Tris,
pH 7.0), then at 300 V constant in clear catode buffer (50 mM
tricine, 15 mM Bis-Tris, pH 7.0) and clear anode buffer until
reaching the end of the gel.
Results
Construction of a psaM-CYP79A1 fusion DNA sequence
for homologous recombination in cyanobacteria
A PsaM-CYP79A1 fusion construct was designed by replacing
the native membrane-spanning N-terminal domain of the
CYP79A1 with the PsaM subunit of cyanobacterial PSI. A fusion
gene of psaM and a codon-optimized version of the sequence
encoding the soluble domain of the CYP79A1 were commercially
synthesized, and flanking regions of the psaM gene and a
kanamycin resistance cassette were cloned into the construct
(Figure S1).
The marine cyanobacterium Synechococcus sp. PCC 7002 was
chosen as photosynthetic host organism. Its available genomic
sequence and natural transformability facilitate genetic engineer-
ing. Additionally, being tolerant to a broad range of environmental
conditions and capable of fast photoautotrophic growth with
simple nutritional requirements, this cyanobacterium is a good
candidate for use in biotechnological applications. Synechococcus
sp. PCC 7002 cells were incubated with the DNA construct to
allow uptake and the native psaM gene was replaced with the
psaM-CYP79A1 gene through homologous recombination.
Verification of the presence of PsaM-CYP79A1 in
transformed cyanobacteria
Transformants were segregated for 4 generations using kana-
mycin as positive selection marker, and colony PCR was
performed to confirm that the fusion gene construct had been
integrated in the Synechococcus sp. PCC 7002 genome. Using
primers binding outside the recombined sequence, it was verified
that a DNA construct with a size corresponding to the psaM-
CYP79A1 fusion gene and the kanamycin resistance cassette had
replaced the native psaM gene in the transformed strain (Figure 2
A and B). Only one band was seen for each colony of the
transformed strain, thus indicating that psaM had been replaced
by the fusion construct in all copies of the genome. Moreover,
when the forward primer binding site was located in the CYP79A1
part of the fusion gene or in the kanamycin resistance cassette,
colony PCR products were only obtained for the transformed
strain (data not shown).
RT-PCR was used to investigate if the psaM-CYP79A1 fusion
DNA was transcribed in the cyanobacteria (Figure 2A and C).
RNA was purified from WT and transformed cultures and used
for cDNA synthesis in the presence and absence of reverse
transcriptase. PCR using primer pair e with both the forward and
reverse primer binding in the psaM part of the fusion gene resulted
in a product in both WT and PsaM-CYP79A1 samples. When
primer pair f with the reverse primer binding in the CYP79A1 part
of the fusion gene was used, only the sample with the transformed
strain resulted in a PCR product. In control PCR samples run in
the absence of reverse transcriptase, no bands were seen (data not
shown).
The presence of expressed PsaM-CYP79A1 fusion protein in
thylakoids and trimeric PSI purified from the transformed
Synechococcus sp. PCC 7002 was analysed by immunoblotting.
As positive control, full-length CYP79A1 (,62 kDa) expressed in
Nicotiana benthamiana chloroplasts was used. A band of
approximately the same size, corresponding to the expected size
(,61 kDa) of the fusion of PsaM and the soluble domain of the
CYP79A1, was observed in both thylakoids and trimeric PSI of the
PsaM-CYP79A1 cyanobacteria, whereas no signal was detected in
the WT samples, thus indicating that the PsaM-CYP79A1 fusion
was expressed in the transformed cyanobacteria (Figure 2D) and
present in at least a fraction of the trimeric PSI complexes.
PsaM-CYP79A1 localization
Having established that the fusion protein is expressed we
analysed the localisation of the protein in more detail. In the
immunoblot analysis in Figure 2D, the samples contained
thylakoids and PSI trimers corresponding to 10 and 50 mg Chl,
respectively. The thylakoid sample thus contained much less PSI
complexes than the PSI trimer sample. A stronger signal was
clearly detected from the thylakoid sample, indicating that a large
part of the PsaM-CYP79A1 fusion present in the thylakoids is not
associated with the PSI trimers after purification. This was
confirmed in an independent experiment by analysing the
presence of PSI, PSII and CYP79A1 by immunoblot analysis of
representative fractions of a sucrose gradient separating solubilized
membrane components of the thylakoids using antibodies against
the PSI-subunit PsaC, the PSII-subunit PsbA and the CYP79A1
(Figure 3). While a small fraction of the PsaM-CYP79A1 co-
migrated with the PSI trimers, most PsaM-CYP79A1 was detected
in fractions of the sucrose gradient shifted towards smaller
complexes than the photosynthetic protein complexes
(Figure 3A). This indicates that the PsaM-CYP79A1 fusion is
not firmly attached to the PSI trimers nor monomers. It is possible
that the PsaM-CYP79A1 fusion is associated with PSI in the intact
membranes, but most PsaM-CYP79A1 is not bound to PSI upon
detergent-mediated solubilisation of the thylakoid membrane.
An increase in the abundance of the PSI monomer band was
observed in the sucrose gradient with thylakoids from the PsaM-
CYP79A1 strain compared to the gradient prepared from wild
type thylakoids (Figure 3B). This increase in PSI monomers in the
engineered strain was likewise verified by BN-PAGE (Figure 3C).
In vivo PsaM-CYP79A1 activity
The in vivo enzymatic activity of CYP79A1 in the engineered
PsaM-CYP79A1 strain was investigated by analysing extracts of
cyanobacteria cells and growth medium by LC-MS. WT and
PsaM-CYP79A1 cultures were grown to an OD730 of 2.5 before
they were harvested and metabolites from the cyanobacteria cells
and the growth medium were extracted in ethyl acetate and
methanol. The samples were analysed by LC-MS in APCI mode.
Extracted ion chromatograms (EIC) were created corresponding
to [M+H]+ (m/z 152) for p-hydroxyphenylacetaldoxime. The
results are shown in Figure 4.
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Only the PsaM-CYP79A1 samples contained a product with
retention times identical to those of the oxime standard, thus
clearly demonstrating that the engineered cyanobacterial strain
can convert tyrosine into the corresponding oxime and that the
PsaM-CYP79A1 fusion is enzymatically active in vivo in
cyanobacteria (Figure 4A). Interestingly, the oxime was detected
almost exclusively in the growth medium, implying that the
product is excreted from the cyanobacteria (Figure 4B). At OD730
= 2.5, the oxime content was found to be approximately 4 ng/mL
culture in the growth medium of the PsaM-CYP79A1 strain. The
expression and enzymatic activity of the PsaM-CYP79A1 fusion
protein in the cyanobacteria had no apparent impact on growth of
the cyanobacteria cells compared with the wild type (data not
shown).
PsaM-CYP79A1 activity in isolated thylakoids
Having demonstrated that the PsaM-CYP79A1 fusion enzyme
was active in vivo, we now turned to in vitro studies with purified
thylakoids. Enzymatic activity assays were performed to verify that
the oxime production by the PsaM-CYP79A1 fusion indeed was
light-driven. Isolated thylakoids were incubated with tyrosine
(radiolabelled or unlabelled) in the presence of electron donors for
PSI and Fd for mediation of electron transport from PSI to the
CYP79A1 [2,13]. The activity assay was performed under
illumination in the presence of detergent to disrupt the thylakoids
and allow access of the added electron donors to the oxidizing site
of PSI. After completion of the assay, hydrophobic metabolites
were extracted from the assay mixture with ethyl acetate. The
components of the samples prepared with radiolabelled tyrosine as
substrate were separated by TLC and analysed by autoradiogra-
phy using storage phosphor screens. Unlabelled tyrosine samples
were analysed by LC-MS. Oxime produced in the assays was
identified through comparison with an oxime standard.
Figure 5A shows the in vitro formation of radiolabelled oxime
by WT and PsaM-CYP79A1 thylakoids in the light or in the dark.
Only the PsaM-CYP79A1 thylakoids were able to produce oxime.
Figure 2. Gene construct and verification of transformation. A) Schematic representation of binding sites for primers used for colony PCR
(primer pair d, subpanel B) and RT-PCR (primer pair e and f, subpanel C) in the transformed Synechococcus sp. PCC 7002 genomic DNA. The black lines
represent the gDNA that is not part of the cloning construct. The same forward primer is used in primer pair e and f. The primers are shown in Table 1.
B) Colony PCR analysis of WT and transformed Synechococcus sp. PCC 7002 colonies performed using primer pair d. The sizes of the bands correlate
well with the expected sizes of 4841 bp (PsaM-CYP79A1 strain) and 2344 bp (WT) indicating that the fusion construct has replaced the native psaM
gene in the transformed strain. C) RT-PCR analysis of the transcription of the psaM-CYP79A1 fusion gene. The sizes of the fragments fit the expected
77 bp for primer pair e (expected in both WT and PsaM-CYP79A1) and 142 bp for primer pair f (only expected for PsaM-CYP79A1). D) Immunoblot of
WT and transformant thylakoid (proteins corresponding to 10 mg Chl) and trimeric PSI (proteins corresponding to 50 mg Chl) samples with an anti-
CYP79A1 antibody. C+: CYP79A1 expressed in chloroplasts of tobacco. The expected molecular masses of the CYP79A1 with its native membrane
anchor (C+) and the PsaM-CYP79A1 are ,62 kDa and ,61 kDa, respectively, deduced from the corresponding DNA sequences.
doi:10.1371/journal.pone.0102184.g002
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Oxime formation was only seen in light-incubated samples with a
27 fold increase in signal compared to dark-incubated samples,
thereby demonstrating that the oxime formation was light-driven
and indicating that the PsaM-CYP79A1 was indeed fuelled with
electrons delivered from PSI.
Figure 5B shows the oxime production in PsaM-CYP79A1
thylakoids as a function of tyrosine concentration. An increase in
the production level was seen up to a concentration of 0.5 mM
tyrosine. At higher concentrations, the PsaM-CYP79A1 appears to
be substrate inhibited. At a substrate concentration of 0.5 mM
Figure 3. Localization of the PsaM-CYP79A1 fusion protein in the thylakoids. A) Immunoblot of proteins from 80 mL of the 0.5 mL fractions
collected from the PsaM-CYP79A1 sucrose gradient shown in panel B), concentrated through acetone precipitation. Antibodies against the PSI
subunit PsaC (,9 kDa), the PSII subunit PsbA (,32 kDa) and the CYP79A1 (,61 kDa) have been used. CYP79A1, d.e.: digitally enhanced
representation of the chemiluminescence signal detected from the CYP79A1 bands (shown below). C+: CYP79A1 expressed in chloroplasts of
tobacco. Fraction 1 is the bottommost and fraction 28 the topmost fraction in the gradient. B) Sucrose gradients separating the components of WT
and PsaM-CYP79A1 thylakoids solubilized in 1% (w/v) b-DM. C) Separation of protein complexes of b-DM-solubilized WT and PsaM-CYP79A1
thylakoids by BN-PAGE.
doi:10.1371/journal.pone.0102184.g003
Figure 4. Verification of product formation in living cells. A) Extracted ion chromatograms (m/z 152) from the LC-MS analysis of metabolites
extracted from the growth medium of Synechococcus sp. PCC 7002 WT and PsaM-CYP79A1 cultures for detection of in vivo activity of the PsaM-
CYP79A1 complex, compared to a p-hydroxyphenylacetaldoxime standard (C+). The two peaks are the E and Z isomers of the p-
hydroxyphenylacetaldoxime. B) LC-MS extracted ion chromatograms as in A, from analysis of extracts of PsaM-CYP79A1 cyanobacteria or growth
medium.
doi:10.1371/journal.pone.0102184.g004
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tyrosine, approximately 12 ng oxime was produced by thylakoids
corresponding to 100 mg Chl during a 30 min assay.
Discussion
Light-driven oxime production by an engineered
cyanobacterium
In this work, we have genetically linked the catalytic domain of
the CYP79A1 from the plant S. bicolor to the PSI subunit PsaM in
Synechococcus sp. PCC 7002 with the aim to target the CYP79A1
to the vicinity of PSI to obtain light-driven P450 biosynthesis. The
PsaM-CYP79A1 fusion protein was found to be located in the
thylakoids of the cyanobacterial host with a smaller fraction
directly attached to the PSI complex. The fusion protein was
functional in vivo with the CYP79A1 enzymatic activity being
sustained by endogenously produced tyrosine and the product, p-
hydroxyphenylacetaldoxime, being excreted into the growth
medium (Figure 4). Through in vitro assays, the enzymatic
reaction was confirmed to be light-driven, indicating that the
electrons powering the PsaM-CYP79A1 catalytic cycle were
indeed photosynthetic electrons delivered from PSI (Figure 5).
Cytochrome P450s are key enzymes in the biosynthesis of the
majority of the numerous bioactive specialized metabolites with
medicinal properties produced by plants. For many of these
compounds, the biosynthesis in the plants is tightly regulated with
the production levels often being low or highly variable, dependent
on induction by abiotic or biotic factors and confined to specific
growth stages and cell types, thus making extraction, purification
and separation from structurally similar compounds a challenge
[3,4,8,9]. This study demonstrates that it is possible to express
plant P450s in the thylakoids of a cyanobacterium to obtain a
light-driven production system as an environmentally friendly
alternative to production through chemical synthesis.
As the P450 fold is highly conserved, and since delivery of
electrons from PSI to both the CYP79A1 from S. bicolor and the
CYP124 from M. tuberculosis via Fd have been shown to function
in vitro, it is probable that the light-driven biosynthesis approach is
generally applicable to a variety of P450s [13,21,31].
In addition to uncoupling from the tight metabolic regulation
that the enzyme is often subjected to in the native host, an
advantage of heterologous expression in a microorganism is the
potential for future scale-up of production to an industrial level.
The commercial use of cyanobacterial production systems is still in
its developing phase, but recently cyanobacteria have attracted
interest due to their green bioindustrial potential. The simple
nutritional growth requirements, constituting only water, CO2 and
a few mineral nutrients, with sunlight as the only necessary energy
source, suggest a potential for inexpensive and renewable
production of for instance biofuels and valuable natural products.
Cyanobacterium-based production systems thus offer an alterna-
tive to the carbohydrate-fed approaches necessary for the
microorganisms primarily employed in biotechnology [32–35].
The oxime produced by the PsaM-CYP79A1 in this study was
excreted into the growth medium, a phenomenon that has also
earlier been observed for heterologous production of caffeic acid
and the monoterpene b-phellandrene in the cyanobacterium
Synechocystis sp. PCC 6803, and that with these compounds
facilitate easy product isolation [36,37]. However, more knowl-
edge about the secretion mechanism is needed before we can take
full advantage of this phenomenon.
Electron partitioning and fusion construct design
For the cyanobacterium to be viable while supplying electrons
for the PsaM-CYP79A1, electron delivery should be possible not
only to the P450, but also to other processes in the thylakoid
environment dependent on reduction by Fd. It was thus decided
not to attempt to obtain direct electron transfer from the terminal
Fe4S4 clusters of PSI to the CYP79A1, as has been the aim for in
vitro coupling of hydrogenases or metal catalysts to PSI, but rather
to rely on electron transfer via Fd [38–42]. It was chosen to anchor
the CYP79A1 to the peripheral PsaM subunit of PSI where the
P450 would be expected not to prevent access of Fd to its docking
site at PSI [22]. Though most CYP79A1 appeared not to be
directly associated with PSI, at least after purification, the
engineered CYP79A1 was found to be located in the thylakoids
and active without its native membrane anchor, demonstrating the
Figure 5. Evidence for light-driven CYP79A1 activity. In vitro PsaM-CYP79A1 enzyme activity assays. A) Using radiolabelled tyrosine as
substrate, assays were run using WT and PsaM-CYP79A1 thylakoids incubated at 25uC for 30 min under 200 mmol?m22?s21 illumination or in the dark.
The produced radiolabelled oxime was detected by laser scanning of a storage phosphor screen incubated with the TLC plate on which the extracted
cyanobacterial metabolites were separated. The data represent averages of 5 measurements and error bars show standard deviations. B) PsaM-
CYP79A1 thylakoids were assayed as in A), but with unlabelled tyrosine, and metabolite extracts were analysed by LC-MS. The result from a typical
experiment is shown.
doi:10.1371/journal.pone.0102184.g005
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possibility of engineering P450s without inactivating the enzymatic
capability. This suggests that it may be possible to develop other
P450 fusion proteins for this light-driven setup, possibly providing
increased production levels through improved competitiveness for
reduced Fd.
Association of PsaM-CYP79A1 and PSI?
From the immunoblot analysis in Figure 2 and 3, the main part
of the PsaM-CYP79A1 fusion protein was found not to co-
fractionate with the PSI complex. It could be that most PsaM-
CYP79A1 has never been associated with PSI, but it is also
possible that the PsaM-CYP79A1 is loosely connected to PSI in
the intact membranes, but that the complexes disintegrate upon
membrane solubilisation. The added size of the CYP79A1 domain
on the PsaM protein could result in steric hindrances and thereby
weakened interactions between the PsaM and the remaining PSI
complex.
The PsaM subunit has previously been found to stabilize, but
not be strictly needed, for the assembly of PSI trimers in a psaM–
mutant of Synechocystis sp. PCC 6803 [43]. The increased
abundance of PSI monomers observed following expression of
PsaM-CYP79A1 (Figure 3) could thus be explained by a reduction
in the number of stable trimers due to the absence of the PsaM-
CYP79A1 fusion protein in a majority of the PSI complexes.
Alternatively, trimers containing the PsaM-CYP79A1 could be
present in the membrane, but the inter-complex interactions
weakened due to the CYP79A1, causing the instable trimers to fall
apart during purification.
No impact on growth was detected for the PsaM-CYP79A1
strain compared to the WT despite the observed destabilization or
reduced abundance of PSI trimers in the thylakoids of the PsaM-
CYP79A1 strain. It is to be noted that normal growth was also
observed in the Synechocystis sp. PCC 6803 psaM– mutant [43].
Increasing the yield of light-driven biosynthesis
The compound produced by light-driven biosynthesis in this
project, p-hydroxyphenylacetaldoxime, is chosen for proof-of-
concept. However, for a compound produced for a commercial
application, the product titer would have to be increased from the
current production level of ng/mL culture to be of industrial
relevance. Key parameters in this context will be optimization of
the expression level of the enzymes in the pathway, the supply of
substrate and delivery of electrons to the P450s. Upregulation of
the expression of Fd may lead to an increased supply of electrons
to the P450s, and engineering of the P450 and/or Fd to increase
the affinity of the two proteins for each other may also increase the
ability of the P450 to compete for reduced Fd with FNR. Another
approach that earlier has proved to yield an increase in production
for a P450 was co-expression of a cytochrome b5, which can
stimulate the P450 reaction rate through several possible
mechanisms [44,45].
The flavodiiron proteins Flv1 and Flv3 have been shown to
function as a sink for excess electrons produced in photosynthesis
in cyanobacteria, reducing O2 to water without production of
reactive oxygen species [46]. As the light-driven approach can also
be seen as an additional electron sink, it could be speculated that
knocking down those flavodiiron proteins would increase the need
for an alternative sink and that this perhaps could lead to an
increased supply of electrons to the P450s.
For a pathway containing multiple enzymes, the flux through
the pathway will be important to optimize. This can be
approached by adjusting the relative expression level of the
enzymes, e.g. by changing promoters and ribosome-binding sites,
and increasing the product channelling, which may be improved
e.g. by scaffolding of the enzymes [47–49]. Balancing the protein
expression can however be a challenge, as engineering of
cyanobacteria is still not as well established as engineering of
classic model microorganisms such as E. coli, which has a less
complex metabolism, and even characterized genetic elements can
result in unpredictable expression levels [50].
Conclusion and Perspectives
In this study, we have engineered a fusion enzyme of the
catalytic domain of a plant P450 and a PSI subunit and expressed
it in Synechococcus sp. PCC 7002. The PsaM-CYP79A1 fusion
enzyme is present in the thylakoids and proved to be functional
with light-driven enzymatic activity detected both in vivo and in
vitro. The biosynthesized oxime was found to be excreted into the
growth medium, enabling easy product isolation. These works
demonstrate the possibility of functionally coupling plant enzymes
requiring electrons in their reactions to PSI and utilize the
reducing equivalents generated in the photosynthetic electron
transport chain to obtain light-driven biosynthesis in photosyn-
thetic microorganisms.
It is envisioned that the approach presented here can be
developed as a light-driven and environmentally friendly produc-
tion system for bioactive compounds relevant to the pharmaceu-
tical or chemical industries. In contrast to most enzymes used as
biocatalysts in vitro for industrial purposes, P450s require the
costly cofactor NADPH and a reductase for electron donation, an
issue that is overcome in the light-driven in vivo system presented
here [51]. Cyanobacteria can be efficiently cultivated at industrial
scale and the use of a cyanobacterial host thus provides the
potential for future scale-up of the system.
Supporting Information
Figure S1 Cloning of the PsaM-CYP79A1 fusion con-
struct. Using PCR, a kanamycin resistance cassette was amplified
from a vector containing the cassette (npt cassette from pJHJ08,
[25]) and flanking regions of the psaM gene were amplified from
Synechococcus sp. PCC 7002 gDNA. Primer sequences are shown
in Table 1. The PCR products were inserted in a commercially
synthesized fusion construct of the psaM and CYP79A1 genes
contained in the pUC57 cloning vector. The final construct was
transformed into Synechococcus sp. PCC 7002 for replacement of
the native psaM gene by homologous recombination.
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